Literature DB >> 33089570

Clinical symptoms of hyperandrogenic women diagnosed with COVID-19.

F A Cadegiani1,2, R K Lim3, A Goren4, J McCoy4, M Situm5, M Kovacevic5, S Vañó Galván6, R Sinclair7, A Tosti8, C G Wambier9.   

Abstract

Entities:  

Mesh：

Year:  2020        PMID： 33089570     DOI： 10.1111/jdv.17004

Source DB:  PubMed          Journal:  J Eur Acad Dermatol Venereol        ISSN： 0926-9959            Impact factor:   6.166


× No keyword cloud information.
  16 in total

1.  Final Results of a Randomized, Placebo-Controlled, Two-Arm, Parallel Clinical Trial of Proxalutamide for Hospitalized COVID-19 Patients: A Multiregional, Joint Analysis of the Proxa-Rescue AndroCoV Trial.

Authors:  Flavio A Cadegiani; Ricardo A Zimerman; Daniel N Fonseca; Michael N Correia; Marcio P Muller; Diego Leonardo Bet; Marcio Rafael Slaviero; Ivan Zardo; Paulo Roberto Benites; Renan N Barros; Raysa W Paulain; Dirce C Onety; Karla Cristina P Israel; Carlos Gustavo Wambier; Andy Goren
Journal:  Cureus       Date:  2021-12-25

Review 2.  Androgens in SARS-CoV-2 coronavirus infections.

Authors:  L Stárka; M Dušková
Journal:  Physiol Res       Date:  2021-12-16       Impact factor: 1.881

3.  Comment on "Androgens and women: COVID-19 outcomes in women with acne vulgaris, polycystic ovarian syndrome, and hirsutism".

Authors:  Ayman Abdelmaksoud; Mohamad Goldust; Michelangelo Vestita
Journal:  Int J Dermatol       Date:  2021-04-20       Impact factor: 3.204

4.  Early Antiandrogen Therapy With Dutasteride Reduces Viral Shedding, Inflammatory Responses, and Time-to-Remission in Males With COVID-19: A Randomized, Double-Blind, Placebo-Controlled Interventional Trial (EAT-DUTA AndroCoV Trial - Biochemical).

Authors:  Flavio A Cadegiani; John McCoy; Carlos Gustavo Wambier; Andy Goren
Journal:  Cureus       Date:  2021-02-01

5.  Proxalutamide Significantly Accelerates Viral Clearance and Reduces Time to Clinical Remission in Patients with Mild to Moderate COVID-19: Results from a Randomized, Double-Blinded, Placebo-Controlled Trial.

Authors:  Flavio A Cadegiani; John McCoy; Carlos Gustavo Wambier; Sergio Vaño-Galván; Jerry Shapiro; Antonella Tosti; Ricardo A Zimerman; Andy Goren
Journal:  Cureus       Date:  2021-02-22

6.  The AndroCoV Clinical Scoring for COVID-19 Diagnosis: A Prompt, Feasible, Costless, and Highly Sensitive Diagnostic Tool for COVID-19 Based on a 1757-Patient Cohort.

Authors:  Flavio A Cadegiani; Ricardo A Zimerman; Bruno Campello de Souza; John McCoy; Rute Alves Pereira E Costa; Carlos Gustavo Wambier; Andy Goren
Journal:  Cureus       Date:  2021-01-07

7.  Potential risk for developing severe COVID-19 disease among anabolic steroid users.

Authors:  Flavio Cadegiani; Erica M Lin; Andy Goren; Carlos G Wambier
Journal:  BMJ Case Rep       Date:  2021-02-26

Review 8.  Androgenetic alopecia and COVID-19: A review of the hypothetical role of androgens.

Authors:  Hamideh Moravvej; Mohammad Reza Pourani; Moein Baghani; Fahimeh Abdollahimajd
Journal:  Dermatol Ther       Date:  2021-06-09       Impact factor: 3.858

9.  Early COVID-19 therapy with azithromycin plus nitazoxanide, ivermectin or hydroxychloroquine in outpatient settings significantly improved COVID-19 outcomes compared to known outcomes in untreated patients.

Authors:  F A Cadegiani; A Goren; C G Wambier; J McCoy
Journal:  New Microbes New Infect       Date:  2021-07-07

10.  Isotretinoin in acne treatment during the coronavirus disease 2019 (COVID-19): A retrospective analysis of adherence to therapy and side effects.

Authors:  Marianna Donnarumma; Mariateresa Nocerino; Wanda Lauro; Maria Carmela Annunziata; Claudio Marasca; Gabriella Fabbrocini
Journal:  Dermatol Ther       Date:  2020-12-22       Impact factor: 3.858
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.